PMID- 27180224 OWN - NLM STAT- MEDLINE DCOM- 20170711 LR - 20181202 IS - 1553-4669 (Electronic) IS - 1553-4650 (Print) IS - 1553-4650 (Linking) VI - 23 IP - 6 DP - 2016 Sep-Oct TI - Cosmetic Appearance of Port-site Scars 1 Year After Laparoscopic Versus Robotic Sacrocolpopexy: A Supplementary Study of the ACCESS Clinical Trial. PG - 917-21 LID - S1553-4650(16)30072-3 [pii] LID - 10.1016/j.jmig.2016.05.001 [doi] AB - STUDY OBJECTIVE: To prospectively measure trocar site appearances 1 year after surgery in women participants in the Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies Trial, a 2-center randomized surgical trial (NCT01124916). DESIGN: Supplementary analysis of a surgical trial that randomized women to robotic or laparoscopic sacrocolpopexy (Canadian Task Force classification I). SETTING: Operative trial. PATIENTS: Women undergoing clinically indicated sacrocolpopexy for symptomatic stage >/=II pelvic organ prolapse were randomized to laparoscopic abdominal sacrocolpopexy (LASC) or robotic abdominal sacrocolpopexy (RASC). Trocar skin incision closure was standardized by using Dermabond (Ethicon, Somerville, NJ). MEASUREMENTS AND MAIN RESULTS: Photographs of all incision sites were taken at baseline (immediately), 6 weeks, 6 months, and 1 year after surgery. Study coordinators scored each incision with the validated Stony Brook Evaluation Scale (SBES), a 5-point wound evaluation scale. We calculated the average of all scars scores per case to determine the percent of optimal wound healing (0%-100%) for each case as well as the proportion of cases meeting 100% wound repair scoring. Wound repair scores across groups were tested with the Wilcoxon rank sum test. The overall proportion of cases in each group meeting "optimal" wound recovery (scores of 100%) was tested with the Fisher exact test. Seventy-eight women with a mean age of 59 years (range, 26-79 years) were randomized to LASC (n = 38) or RASC (n = 40). We did not detect significant differences in baseline characteristics or rates of dropout between the 2 study groups (5 in LASC and 7 in RASC, p = .60). Pain in the initial postoperative period was higher in the robotic arm although groups were similar at 2 weeks. Nearly all cases (75/78) contributed wound repair data (36 laparoscopic and 39 robotic). Laparoscopic surgeries require significantly fewer incisions (median = 4; range, 4-6) than robotic surgeries (median = 5; range, 4-6; p < .001). SBES scores at 6 weeks were not different for LASC and RASC (p = .426). By 6 months, the scores were better in the LASC group (84.8% +/- 8.8% vs 78.5% +/- 7.2%, p = .031), and this finding remained at 1 year (93.4% +/- 7.2% vs 85.9% +/- 8.8%, p = .001). The proportion of cases with optimal wound repair (score of 100%) was higher in the laparoscopic arm at 1 year after surgery (12/27 vs 4/33, p = .008). INTERVENTIONS: Women were randomized to robotic assisted laparoscopy or laparoscopy. CONCLUSION: Wound appearance using the SBES was better in the LASC group, suggesting that there may be alterations in the mechanism for wound initiation and/or healing based on the minimally invasive route used for sacrocolpopexy. CI - Copyright (c) 2016 AAGL. Published by Elsevier Inc. All rights reserved. FAU - Mueller, Elizabeth Rose AU - Mueller ER AD - Departments of Obstetrics/Gynecology and Urology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois. Electronic address: emuelle@lumc.edu. FAU - Kenton, Kimberly AU - Kenton K AD - Departments of Obstetrics/Gynecology and Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. FAU - Anger, Jennifer T AU - Anger JT AD - Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California. FAU - Bresee, Catherine AU - Bresee C AD - Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, California. FAU - Tarnay, Christopher AU - Tarnay C AD - Department of Obstetrics/Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. LA - eng SI - ClinicalTrials.gov/NCT01124916 GR - L30 DK089590/DK/NIDDK NIH HHS/United States GR - RC1 EB010649/EB/NIBIB NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial DEP - 20160512 PL - United States TA - J Minim Invasive Gynecol JT - Journal of minimally invasive gynecology JID - 101235322 SB - IM MH - Adult MH - Aged MH - *Cicatrix MH - Esthetics MH - Female MH - Gynecologic Surgical Procedures/adverse effects/*methods MH - Humans MH - *Laparoscopy MH - Middle Aged MH - Pelvic Organ Prolapse/surgery MH - *Postoperative Complications MH - *Robotic Surgical Procedures PMC - PMC5007204 MID - NIHMS786413 OTO - NOTNLM OT - Laparoscopic OT - Prolapse OT - Robotic OT - Sacrocolpopexy OT - Scar OT - Wound healing COIS- Anger JA: Investigator ASTORA Women's Health LLC; investigator/expert witness for Boston Scientific Breese C: Nothing to disclose Kenton K: Grant from Boston Scientific Mueller ER: Nothing to disclose Tarney C: Nothing to disclose EDAT- 2016/05/18 06:00 MHDA- 2017/07/14 06:00 PMCR- 2017/09/01 CRDT- 2016/05/16 06:00 PHST- 2016/03/16 00:00 [received] PHST- 2016/04/22 00:00 [revised] PHST- 2016/05/02 00:00 [accepted] PHST- 2016/05/16 06:00 [entrez] PHST- 2016/05/18 06:00 [pubmed] PHST- 2017/07/14 06:00 [medline] PHST- 2017/09/01 00:00 [pmc-release] AID - S1553-4650(16)30072-3 [pii] AID - 10.1016/j.jmig.2016.05.001 [doi] PST - ppublish SO - J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):917-21. doi: 10.1016/j.jmig.2016.05.001. Epub 2016 May 12.